Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.

Researchers used nearly 150,000 chest X-rays to train an artificial intelligence program to identify patterns in the images associated with risk from major cardiovascular disease events. They tested ...

Definitive chemoradiation for oligometastatic esophageal cancer patients. PIONEER: A multicenter, open-label, randomized phase II trial of second-line apatinib plus chemotherapy versus chemotherapy ...

Don't dismiss chest discomfort, bloating, or burping as mere indigestion. Cardiologists warn these can be silent heart attack signs, often lacking classic chest pain. Subtle symptoms like nausea, ...